Primary carnitine deficiency (PCD)
Evidence-based neurology checklist on primary carnitine deficiency (pcd): Genetics This is caused by mutations in the SLC22A5 gene The gene encodes organic cation transporter type 2 (OCTN2) The transmission is autosomal recessive Systemic features Cardiac features Neurological features Baseline…
Genetics
- This is caused by mutations in the SLC22A5 gene
- The gene encodes organic cation transporter type 2 (OCTN2)
- The transmission is autosomal recessive
Systemic features
Cardiac features
Neurological features
Baseline investigations
Differentials: causes of secondary carnitine deficiency
Treatment
References
- Magoulas PL, El-Hattab AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 2012; 7:68.
- Liang WC, Nishino I. Lipid storage myopathy. Curr Neurol Neurosci Rep 2011; 11: 97-103.
- Crefcoeur LL, Visser G, Ferdinandusse S, Wijburg FA, Langeveld M, Sjouke B. Clinical characteristics of primary carnitine deficiency: a structured review using a case-by-case approach. J Inherit Metab Dis 2022; 45:386-405.
- Khries M, Lim A, Mitra D, et al. Broadening the spectrum of SLC22A5 phenotype: primary carnitine deficiency presenting with focal myoclonus. Child Neurol Open 2023; 10:2329048X231184183.
- Uppin MS, Sundaram C, Meena AK, et al. Lipid storage myopathies with unusual clinical manifestations. Neurol India 2008; 56:391-393.
- And 1 more. Subscribe to see the full list
